2B2X image
Deposition Date 2005-09-19
Release Date 2006-04-18
Last Version Date 2024-11-13
Entry Detail
PDB ID:
2B2X
Keywords:
Title:
VLA1 RdeltaH I-domain complexed with a quadruple mutant of the AQC2 Fab
Biological Source:
Source Organism:
Rattus norvegicus (Taxon ID: 10116)
Mus musculus (Taxon ID: 10090)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Free:
0.27
R-Value Work:
0.23
R-Value Observed:
0.24
Space Group:
P 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Integrin alpha-1
Gene (Uniprot):Itga1
Mutations:G217V, R218Q, Q219R, L222R
Chain IDs:A, D (auth: B)
Chain Length:223
Number of Molecules:2
Biological Source:Rattus norvegicus
Polymer Type:polypeptide(L)
Molecule:Antibody AQC2 Fab
Mutations:T50V, K64E
Chain IDs:B (auth: H), E (auth: I)
Chain Length:226
Number of Molecules:2
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:Antibody AQC2 Fab
Mutations:S28Q, N52Y
Chain IDs:C (auth: L), F (auth: M)
Chain Length:213
Number of Molecules:2
Biological Source:Mus musculus
Ligand Molecules
Primary Citation
Affinity enhancement of an in vivo matured therapeutic antibody using structure-based computational design
Protein Sci. 15 949 960 (2006)
PMID: 16597831 DOI: 10.1110/ps.052030506

Abstact

Improving the affinity of a high-affinity protein-protein interaction is a challenging problem that has practical applications in the development of therapeutic biomolecules. We used a combination of structure-based computational methods to optimize the binding affinity of an antibody fragment to the I-domain of the integrin VLA1. Despite the already high affinity of the antibody (Kd approximately 7 nM) and the moderate resolution (2.8 A) of the starting crystal structure, the affinity was increased by an order of magnitude primarily through a decrease in the dissociation rate. We determined the crystal structure of a high-affinity quadruple mutant complex at 2.2 A. The structure shows that the design makes the predicted contacts. Structural evidence and mutagenesis experiments that probe a hydrogen bond network illustrate the importance of satisfying hydrogen bonding requirements while seeking higher-affinity mutations. The large and diverse set of interface mutations allowed refinement of the mutant binding affinity prediction protocol and improvement of the single-mutant success rate. Our results indicate that structure-based computational design can be successfully applied to further improve the binding of high-affinity antibodies.

Legend

Protein

Chemical

Disease

Primary Citation of related structures